NEW YORK/WASHINGTON (Financial Times) -- The Trump administration is set to honor a 15% tariff cap on pharmaceutical imports from the EU and Japan, providing a significant relief from the 100% levy on drugs announced by the US president on Thursday.
Ceiling on pharma levy will be in line with trade deals Tokyo and Brussels have with Washington
U.S. President Donald Trump speaks during the 80th United Nations General Assembly in New York on Sept. 23. Trump posted on his Truth Social platform on Sept 25 that the US would impose 100% tariffs on imports of patented or branded pharmaceuticals beginning on October 1. © Reuters
NEW YORK/WASHINGTON (Financial Times) -- The Trump administration is set to honor a 15% tariff cap on pharmaceutical imports from the EU and Japan, providing a significant relief from the 100% levy on drugs announced by the US president on Thursday.